This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Service Corp. (SCI) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Service Corp. (SCI) delivered earnings and revenue surprises of 4.71% and 3.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Inter Parfums (IPAR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Inter Parfums (IPAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inter Parfums (IPAR) Q1 Sales Advance on Brand Strength
by Zacks Equity Research
Inter Parfums' (IPAR) U.S.-based operations witness remarkable 18% sales growth in the first quarter, primarily driven by the Donna Karan/DKNY and GUESS products.
Inter Parfums (IPAR) Poised on Brand Strength, Expansion Efforts
by Zacks Equity Research
Inter Parfums' (IPAR) product launches, brand extension, expansion through new licenses or acquisitions and solid product demand have been aiding growth.
Why Is Inter Parfums (IPAR) Down 4.1% Since Last Earnings Report?
by Zacks Equity Research
Inter Parfums (IPAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Inter Parfums (IPAR) Benefits From Solid Demand Amid Cost Woes
by Zacks Equity Research
Continuous innovation in developing and marketing its range of fragrances, combined with the strength of the fragrance market, positions Inter Parfums (IPAR) well.
McCormick (MKC) Q1 Earnings Coming Up: Factors to Note
by Zacks Equity Research
McCormick's (MKC) first-quarter performance is likely to reflect the adverse impact of cost inflation. Also, rising SG&A costs are a concern.
Archer Daniels (ADM) Announces Accelerated Share Repurchases
by Zacks Equity Research
Archer Daniels (ADM) announces an accelerated share repurchase agreement to buy back $1 billion of its common stock.
Archer Daniels (ADM) Q4 Earnings Beat, Revenues Dip Y/Y
by Zacks Equity Research
Archer Daniels (ADM) reports lower y/y sales in fourth-quarter 2023 due to a decline in sales across all segments.
Monster Beverage's (MNST) Growth Strategies Progress Well
by Zacks Equity Research
Monster Beverage (MNST) has been gaining from strength in its energy drinks category and product innovations.
COTY Benefits From Solid Beauty Trends and Partnerships
by Zacks Equity Research
Coty (COTY) is well-positioned to capitalize on favorable beauty trends. The company is making several strategic partnerships to enhance its brand portfolio.
Monster Beverage (MNST) Q4 Earnings Miss, Sales Rise Y/Y
by Zacks Equity Research
Monster Beverage (MNST) posts soft fourth-quarter 2023 results, wherein the top and bottom lines miss the Zacks Consensus Estimate.
Inter Parfums (IPAR) Lags Q4 Earnings Estimate, Sales Rise Y/Y
by Zacks Equity Research
Inter Parfums (IPAR) reports fourth-quarter 2023 performance, with earnings declining year over year. Net sales increase on continued demand for its brands.
Inter Parfums (IPAR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Inter Parfums (IPAR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Freshpet (FRPT) Q4 Earnings Top Estimates, Sales Rise Y/Y
by Zacks Equity Research
Freshpet's (FRPT) impressive quarterly results, along with strategic improvements and an optimistic 2024 outlook, indicate a bright future for the company.
The Zacks Analyst Blog Highlights HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte
by Zacks Equity Research
HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte are part of the Zacks top Analyst Blog.
Celsius Holdings (CELH) Q4 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Celsius Holdings' (CELH) fourth-quarter results are likely to reflect gains from effective distribution strategies, strong market penetration, product innovation and operational excellence.
The Zacks Analyst Blog Highlights Colgate-Palmolive, Church & Dwight, Inter Parfums, Lamb Weston and Molson Coors Beverage
by Zacks Equity Research
Colgate-Palmolive, Church & Dwight, Inter Parfums, Lamb Weston and Molson Coors Beverage are part of the Zacks top Analyst Blog.
What Will Global Partners' (GLP) Q4 Earnings Unveil?
by Zacks Equity Research
Global Partners LP (GLP) beat the Zacks Consensus Estimate for earnings in two of the last four quarters and missed in the other two.
Hormel Foods (HRL) Q1 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Hormel Foods' (HRL) fiscal first-quarter results are likely to reflect challenges in the International segment, while capacity expansion endeavors bode well.
Pure Storage (PSTG) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Pure Storage's (PSTG) fourth-quarter performance is likely to have been affected by a delay in the fulfillment of a $41 million non-cancelable product order until next year with a Telco customer.
5 Stocks to Buy That Are Poised to Beat on Earnings This Week
by Nalak Das
We have narrowed our search to five stocks that are poised to beat on earnings this week. These are: HEi, CEG, IPAR, APLS, PCVX.
5 Consumer Staple Stocks to Buy Amid Ongoing Market Volatility
by Ritujay Ghosh
Consumer staple stocks like Colgate-Palmolive Company (CL), Church & Dwight Co., Inc. (CHD), Inter Parfums, Inc. (IPAR), Lamb Weston Holdings, Inc. (LW) and Molson Coors Beverage Company (TAP) are a safe bet amid the ongoing market volatility.
Can AB InBev (BUD) Beat Earnings in Q4 Amid Elevated Costs?
by Zacks Equity Research
AB InBev's (BUD) Q4 results are expected to reflect gains from pricing actions, ongoing premiumization, a strong brand portfolio and revenue management initiatives amid high costs.
Keurig Dr Pepper (KDP) Q4 Earnings Top Estimates, Sales Rise
by Zacks Equity Research
Keurig Dr Pepper's (KDP) fourth-quarter 2023 results benefit from continued brand strength and significant pricing.